IL-8 has demonstrated to be significantly higher in non-survivors compared to survivors of COVID-19, and the dynamic change of the serum IL-8 levels has been correlated with the severity of the disease (Nagant et al., 2020; Li et al., 2021). This evidence concerns the gene CXCL8 and COVID-19.